Total number of voting rights and size of share capital in H. Lundbeck A/S as of 31 August 2007

In accordance with Section 6 of the Danish Statutory Order on
Issuers' Disclosure Obligations, H. Lundbeck A/S is required to
publish the total number of voting rights and the size of the share
capital in H. Lundbeck A/S at the end of each calendar month where
there has been a change.

The share capital in H. Lundbeck A/S consists of one class of shares
and as of 31 August 2007 the share capital amounts to DKK
1,036,398,155 divided into 207,279,631 shares of DKK 5 each and
207,279,631 votes.

Lundbeck contacts


Investors:                   Media:

Jacob Tolstrup               Caroline Broge
Director, Investor Relations Media Relations Manager
+45 36 43 30 79              +45 36 43 26 38
+1 201 350 0187


                      ________________________

Stock Exchange Release No 290 - 31 August 2007

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com